We're nearly there, confident next year will see a changing of the guard. We need to finish this year off strongly with trial results and distribution agreements and cement in some partners next year for cellgro in the striate range and the nerve range. Then i reckon around February next year we will have a good idea on where ati is going to proceed. I will be extremely disappointed if We're not mid 70c range by years end and pushing $2 by mid next year.
OCC chart, page-1884
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
0.120(21.8%) |
Mkt cap ! $134.1M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 68.0¢ | 56.5¢ | $1.895M | 3.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37691 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.57pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |